- Home
- PGEN vs ABSI Comparison
PGEN vs ABSI Comparison
Compare PGEN & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- ABSI
- Stock Information
- Founded
- PGEN 1998
- ABSI 2011
- Country
- PGEN United States
- ABSI United States
- Employees
- PGEN N/A
- ABSI N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- PGEN Health Care
- ABSI Health Care
- Exchange
- PGEN Nasdaq
- ABSI Nasdaq
- Market Cap
- PGEN 371.9M
- ABSI 318.2M
- IPO Year
- PGEN N/A
- ABSI 2021
- Fundamental
- Price
- PGEN $1.18
- ABSI $3.22
- Analyst Decision
- PGEN Buy
- ABSI Strong Buy
- Analyst Count
- PGEN 5
- ABSI 6
- Target Price
- PGEN $6.33
- ABSI $8.50
- AVG Volume (30 Days)
- PGEN 2.3M
- ABSI 5.7M
- Earning Date
- PGEN 11-14-2024
- ABSI 11-12-2024
- Dividend Yield
- PGEN N/A
- ABSI N/A
- EPS Growth
- PGEN N/A
- ABSI N/A
- EPS
- PGEN N/A
- ABSI N/A
- Revenue
- PGEN $3,963,000.00
- ABSI $4,207,000.00
- Revenue This Year
- PGEN N/A
- ABSI $8.57
- Revenue Next Year
- PGEN $402.12
- ABSI $169.72
- P/E Ratio
- PGEN N/A
- ABSI N/A
- Revenue Growth
- PGEN N/A
- ABSI N/A
- 52 Week Low
- PGEN $0.65
- ABSI $2.45
- 52 Week High
- PGEN $1.93
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- PGEN 62.22
- ABSI 53.69
- Support Level
- PGEN $1.05
- ABSI $2.66
- Resistance Level
- PGEN $1.46
- ABSI $2.97
- Average True Range (ATR)
- PGEN 0.16
- ABSI 0.35
- MACD
- PGEN 0.00
- ABSI 0.02
- Stochastic Oscillator
- PGEN 60.00
- ABSI 40.30
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.